Luminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020

AUSTIN, Texas, Feb. 13, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President & CEO, and Harriss Currie, Senior Vice President of Finance and CFO, plan to participate at three investor conferences in March 2020. Morgan Stanley European MedTech & Services Conference in London, England on March 3, 2020: one-on-one investor meetings.... Read more

Consolidated Financial Statements for the Third Quarter Ended December 31, 2019 FY2020 (April 1, 2019 – March 31, 2020)[UNAUDITED]

About Us Message from the president Corporate Data and Subsidiaries Corporate Executives Directions to Takara Bio Quality Assurance Policy Consolidated Subsidiaries Business Outline Bioindustry Gene Therapy News Release Investor Relstions Management Policy Financial Data IR Library Stock Information IR Calendar IR News Disclosure Policy FAQ Contact IR User Guide Products Site About Us Business Outline... Read more

Pacific Biosciences Announces Retirement of Michael Phillips, SVP of Research and Development

MENLO PARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that Michael Phillips has decided to retire from his role as the company’s Senior Vice President of Research and Development as of April 1, 2020.Mr. Phillips has... Read more

Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research

Thermo Fisher Scientific Introduces NGS-Based Solution for Expanded Carrier Screening Research Ion Torrent CarrierSeq ECS Kit consolidates multi-testing approach into a single, end-to-end workflow to facilitate implementation globally CARLSBAD, Calif., Feb. 5, 2020 /PRNewswire/ — Thermo Fisher Scientific today introduced a new next-generation sequencing (NGS)-based solution that enables reproductive health researchers to more efficiently analyze... Read more

PerkinElmer Unveils Advanced Drug Discovery and Disease Research Solutions at SLAS2020

Workstations and high-content screening system automate workflows to help researchers generate invaluable insights WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today introduced new workstations and a high content screening system at SLAS2020 in San Diego (booth #929). These technologies automate workflows so that disease research and drug discovery professionals can... Read more

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema

Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema SANTA CLARA, Calif. , January 16, 2020 Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children... Read more

SPECTRO Introduces its New SPECTROMAXx with iCAL 2.0 ARC/SPARK OES Analyzer

Kleve, Germany, January 14, 2020 – SPECTRO Analytical Instruments has introduced the eighth generation of its SPECTROMAXx with iCAL 2.0 ARC/SPARK OES Analyzer — improved with innovative new capabilities and advancements in performance to achieve fast, accurate elemental analysis precisely tuned for material control and foundry applications. The SPECTROMAXx may well be the industry’s leading OES... Read more

Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy

Spark will continue its operations in Philadelphia as an independent company within the Roche Group             Basel, 17 December 2019 – Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) (“Spark”) today announced the completion of the acquisition following the receipt of regulatory approval from all government authorities required by the merger agreement. Commenting... Read more